AMRI CFO to Present at UBS 2009 Global Life Sciences Conference

• Press Release
• Source: AMRI
• On 8:00 am EDT, Wednesday September 16, 2009

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI - News) announced today that AMRI Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the UBS 2009 Global Life Sciences Conference in New York City on Tuesday, September 22, 2009 at 3:30 p.m. EDT.

Related Quotes

Symbol	Price	Change
AMRI	8.58	0.00

{"s" : "amri","k" : "c10,l10,p20,t10","o" : "","j" : ""}

An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the accessing the company's website at www.amriglobal.com. A replay of the webcast will be available within three hours after the live webcast through October 22, 2009.

Founded in 1991, AMRI provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world’s leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand it contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.

AMRI
Peter Jerome, 518-512-2220
Director of Investor Relations